Boston Scientific announces agreement to acquire Penumbra, Inc.
Acquisition to expand Boston Scientific’s cardiovascular portfolio and further address increasing prevalence of vascular diseases
January 15, 2026
Ready to Advertise?
Learn More
Let’s work together.